首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >WAY-163909 [(7bR,10aR)-1 ,2,3,4,8,9,10,10a-Octahydro-7ibH-cyclopenta-[ib][1,4]diazepino[6,7,1hi]indole]:A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity
【24h】

WAY-163909 [(7bR,10aR)-1 ,2,3,4,8,9,10,10a-Octahydro-7ibH-cyclopenta-[ib][1,4]diazepino[6,7,1hi]indole]:A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity

机译:WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7ibH-cyclopenta- [ib] [1,4] diazepino [6,7,1hi]吲哚] :一种新型的5-羟色胺2C受体选择性激动剂,具有类似临床前抗精神病药的活性

获取原文
获取原文并翻译 | 示例
           

摘要

Serotonin-2C (5-HT_(2C)) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission,with agonists selectively decreasing mesolimbic DA.As antipsychotic efficacy is proposed to be associated with decreased mesolimbic DA neurotransmission by virtue of DA D_2 receptor antagonism,the 5-HT_(2C)-selective receptor agonist,WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1 hi]indole],was evaluated in animal models of schizophrenia and in vivo microdialysis and electrophysiology to determine the effects on mesolimbic and nigrostriatal DA neurotransmission.Similar to clozapine,WAY-163909 (1.7-30 mg/kg i.p.) decreased apo-morphine-induced climbing with little effect on stereotypy and no significant induction of catalepsy.WAY-163909 (0.3-3 mg/kg s.c.) more potently reduced phencyclidine-induced locomotor activity compared with d-amphetamine with no effect on spontaneous activity.WAY-163909 (1.7-17 mg/kg i.p.) reversed MK-801 (5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)-and DOI [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-disrupted prepulse inhibition of startle (PPI) and improved PPI in DBA/2N mice.In conditioned avoidance responding,WAY-163909 (0.3-3 mg/kg i.p.;1-17 mg/kg p.o.) reduced avoidance responding,an effect blocked by the 5-HT_(2B/2C) receptor antagonist SB 206553 [5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole].WAY-163909 (10 mg/kg s.c.) selectively decreased extracellular levels of DA in the nucleus accumbens without affecting the striatum.Likewise,in vivo electrophysiological recordings showed a decrease in the number of spontaneously firing DA neurons in the ventral tegmental area but not in the substantia nigra with both acute and chronic (21-day) administration of WAY-163909 (1-10 mg/kg i.p.).Thus,the profile of the 5-HT_(2C) selective receptor agonist WAY-163909 is similar to that of an atypical antipsychotic and additionally may have rapid onset properties.
机译:血清素2C(5-HT_(2C))受体拮抗剂和激动剂可影响多巴胺(DA)神经传递,激动剂可选择性降低中脑边缘DA。由于DA具有抗精神病功效,可降低中脑边缘DA神经传递。 D_2受体拮抗作用,5-HT_(2C)-选择性受体激动剂,WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta- [b在精神分裂症动物模型中评估了[[1,4]二氮杂[6,7,1 hi]吲哚],并在体内进行了微透析和电生理测定,以确定其对中边缘和黑质纹状体DA神经传递的影响。与氯氮平相似,WAY-163909(腹腔注射1.7-30 mg / kg ip)降低了阿扑吗啡引起的爬升,对定型作用几乎没有影响,并且没有明显的僵直诱导.WAY-163909(0.3-3 mg / kg sc)与d相比更有效地降低了苯环利定诱导的运动活性-苯丙胺对自发活动没有影响.WAY-163909(1.7-17 mg / kg ip)逆转MK-801 (5H-二苯并[a,d]环庚-5,10-亚胺(马来酸二唑西平)-和DOI [1-(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷]破坏惊吓的脉冲前抑制(PPI )和改善DBA / 2N小鼠的PPI。在条件回避反应中,WAY-163909(0.3-3 mg / kg ip; 1-17 mg / kg po)减少回避反应,此作用被5-HT_(2B / 2C)受体拮抗剂SB 206553 [5-甲基-1-(3-吡啶基氨基甲酰基)-1,2,3,5-四氢吡咯并[2,3-f]吲哚]。WAY-163909(10 mg / kg sc)选择性降低同样,体内电生理学记录显示,无论急性还是慢性(21天),腹侧被盖区自发放电的DA神经元数量均减少,但黑质中自发放电的DA神经元数量却没有减少。 )施用WAY-163909(1-10 mg / kg ip)。因此,5-HT_(2C)选择性受体激动剂WAY-163909的概况与非典型抗精神病药相似,并且可能起病迅速属性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号